Cognitive impairment, genomic instability and trace elements

Journal of Nutrition, Health and Aging

Volumn 19, Issue 1, 2015, Pages 48-57

  Meramat, A ^a   Rajab, N F ^a   Shahar, S ^a   Sharif, Razinah ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Cognitive impairment; DNA damage; elderly; oxidative damage; telomere; trace elements

Indexed keywords

CALCIUM; COPPER; MERCURY; SELENIUM; TRACE ELEMENT; ANTIOXIDANT;

AGING; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CHROMOSOMAL INSTABILITY; COGNITION; COGNITIVE DEFECT; DNA DAMAGE; DNA REPLICATION; GENOMIC INSTABILITY; HOMEOSTASIS; HUMAN; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PRIORITY JOURNAL; SENESCENCE; TELOMERE; TELOMERE SHORTENING; COGNITION DISORDERS; DEFICIENCY; DIET; GENETICS; METABOLISM; MITOCHONDRION; NUTRIGENOMICS; PATHOLOGY;

AGING; ANTIOXIDANTS; COGNITION DISORDERS; DIET; DNA DAMAGE; GENOMIC INSTABILITY; HUMANS; MITOCHONDRIA; NUTRIGENOMICS; OXIDATIVE STRESS; TELOMERE; TRACE ELEMENTS;

EID: 84921054482     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-014-0489-1     Document Type: Article

References (102)

1. Venne R. Mainstreaming the concerns of older persons into the social development agenda. United Nations Secretariat Division for Social Policy and Development, 2005.
2. Swerdlow RH. The neurodegenerative mitochondriopathies. J Alzheimers Dis 2009;17 (4):737–751.
3. Petrozzi L, Lucetti C, Scarpato R, Gambaccini G, Trippi F, Bernardini S, Del Dotto P, Migliore L, Bonuccelli U. Cytogenetic alterations in lymphocytes of Alzheimer’s disease and Parkinson’s disease patients. Neurol Sci 2002;23 (2):s97–s98. doi:10.1007/s100720200087
4. Trippi F, Botto N, Scarpato R, Petrozzi L, Bonuccelli U, Latorraca S, Sorbi S, Migliore L. Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer’s disease patients. Mutagenesis 2001;16 (4):323–327. doi:10.1093/mutage/16.4.323
5. Fenech MF. Dietary reference values of individual micronutrients and nutriomes for genome damage prevention: current status and a road map to the future. The American Journal of Clinical Nutrition 2010;91 (5):1438S–1454S. doi:10.3945/ajcn.2010.28674D
6. Deary IJ, Corley J, Gow AJ, Harris SE, Houlihan LM, Marioni RE, Penke L, Rafnsson SB, Starr JM. Age-associated cognitive decline. British Medical Bulletin 2009;92 (1):135–152. doi:10.1093/bmb/ldp033
7. Hedden T, Gabrieli JD. Insights into the ageing mind: a view from cognitive neuroscience. Nature reviews Neuroscience 2004;5 (2):87–9.
8. Park DC, Reuter-Lorenz P. The adaptive brain: aging and neurocognitive scaffolding. Annual review of psychology 2009;60:173–19.
9. Raz N, Rodrigue KM. Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neuroscience & Biobehavioral Reviews 2006;30 (6):730–748.
10. Chan R, Chan D, Woo J. A cross sectional study to examine the association between dietary patterns and cognitive impairment in older Chinese people in Hong Kong. The Journal Of Nutrition, Health & Aging 2013;17 (9):757–765. doi:10.1007/s12603-013-0348-5
11. Ismail F, Anjum MR, Mamon AN, Kazi TG. Trace Metal Contents of Vegetables and Fruits of Hyderabad Retail Market. Pakistan Journal of Nutrition 2011;10 (4):365–37.
12. Ordovas JM. Nutrition and cognitive health. In Foresight Mental Capital and Wellbeing Project. Final Project Report London: The Government Office for Science, 2008.
13. Sfar S, Jawed A, Braham H, Amor S, Laporte F, Kerkeni A. Zinc, copper and antioxidant enzyme activities in healthy elderly Tunisian subjects. Experimental Gerontology 2009;44 (12):812–817.
14. Salgueiro MaJ, Zubillaga MB, Lysionek AE, Caro RA, Weill R, Boccio JR. The role of zinc in the growth and development of children. Nutrition 2002;18 (6):510–519.
15. Sandstead HH, Frederickson CJ, Penland JG. History of Zinc as Related to Brain Function. The Journal of Nutrition 2000;130 (2):496
16. Savarino L, Granchi D, Ciapetti G, Cenni E, Ravaglia G, Forti P, Maioli F, Mattioli R. Serum concentrations of zinc and selenium in elderly people: results in healthy nonagenarians/centenarians. Experimental Gerontology 2001;36 (2):327–339.
17. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. Journal of Trace Elements in Medicine and Biology 2006;20 (1):3–18.
18. Mocchegiani E, Costarelli L, Giacconi R, Cipriano C, Muti E, Tesei S, Malavolta M. Nutrient-gene interaction in ageing and successful ageing: A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mechanisms of Ageing and Development 2006;127 (6):517–525.
19. Hill T, Meunier N, Andriollo-Sanchez M, Ciarapica D, Hininger-Favier I, Polito A, O’Connor JM, Coudray C, Cashman KD. The relationship between the zinc nutritive status and biochemical markers of bone turnover in older European adults: the ZENITH study. European Journal of Clinical Nutrition 2005;59 (supplement 2):73–7.
20. Marcellini F, Giuli C, Papa R, Gagliardi C, Dedoussis G, Herbein G, Fulop T, Monti D, Rink L, Jajte J, Mocchegiani E. Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study. Biogerontology 2006;7 (5–6):339–345. doi:10.1007/s10522-006-9048-4
21. Noseworthy MD, Bray TM. Zinc deficiency exacerbates loss in blood-brain barrier integrity induced by hyperoxia measured by dynamic MRI. Proceedings of the Society for Experimental Biology and Medicine 2000;223 (2):175–18.
22. Ho E, Ames BN. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NF?B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proceedings of the National Academy of Sciences 2002;99 (26):16770–16775. doi:10.1073/pnas.222679399
23. Gao S, Jin Y, Hall KS, Liang C, Unverzagt FW, Ma F, Cheng Y, Shen J, Cao J, Matesan J, Li P, Bian J, Hendrie HC, Murrel JR. Selenium level is associated with apoE e4 in rural elderly Chinese. Public Health Nutrition 2009;12 (12):2371–237.
24. Brown KM, Arthur JR. Selenium, selenoproteins and human health: a review. Public Health Nutrition 2001;4 (2B):593–59.
25. Burk RF. Selenium, an Antioxidant Nutrient. Nutrition in Clinical Care 2002;5 (2):75–79. doi:10.1046/j.1523-5408.2002.00006
26. Schweizer U, Schomburg L. Selenium, selenoproteins and brain function. In: Hatfield D, Berry M, Gladyshev V (eds) Selenium. Springer US, 2006;pp 233–248. doi:10.1007/0-387-33827-6_21
27. Gao S, Jin Y, Hall KS, Liang C, Unverzagt FW, Ji R, Murrell JR, Cao J, Shen J, Ma F, Matesan J, Ying B, Cheng Y, Bian J, Li P, Hendrie HC. Selenium Level and Cognitive Function in Rural Elderly Chinese. American Journal of Epidemiology 2007;165 (8):955–965. doi:10.1093/aje/kwk073
28. Gao S, Jin Y, Hall KS, Liang C, Unverzagt FW, Ma F, Cheng Y, Shen J, Cao J, Matesan J, Li P, Bian J, Hendrie HC, Murrell JR. Selenium level is associated with apoE e4 in rural elderly Chinese. Public Health Nutrition 2009;12 (12):2371–2376. doi:doi:10.1017/S1368980009005102
29. Dietrich AM, Glindemann D, Pizarro F, Gidi V, Olivares M, Araya M, Camper A, Duncan S, Dwyer S, Whelton AJ, Younos T, Subramanian S, Burlingame GA, Khiari D, Edwards M. Health and aesthetic impacts of copper corrosion on drinking water. Water science and technology: a journal of the International Association on Water Pollution Research 2004;49 (2):55–6.
30. Morris M, Evans DA, Tangney CC, et al. DIetary copper and high saturated and trans fat intakes associated with cognitive decline. Archives of Neurology 2006;63 (8):1085–1088. doi:10.1001/archneur.63.8.1085
31. Salustri C, Barbati G, Ghidoni R, Quintiliani L, Ciappina S, Binetti G, Squitti R. Is cognitive function linked to serum free copper levels? A cohort study in a normal population. Clinical Neurophysiology 2010;121 (4):502–507.
32. Squitti R, Ghidoni R, Scrascia F, Benussi L, Panetta V, Pasqualetti P, Moffa F, Bernardini S, Ventriglia M, Binetti G, Rossini PM. Free Copper Distinguishes Mild Cognitive Impairment Subjects from Healthy Elderly Individuals. Journal of Alzheimer’s Disease 2011;23 (2):239–248. doi:10.3233/JAD-2010-10109.
33. Lam PK, Kritz-Silverstein D, Barrett Connor E, Milne D, Nielsen F, Gamst A, Morton D, Wingard D. Plasma trace elements and cognitive function in older men and women: the Rancho Bernardo study. The Journal Of Nutrition, Health & Aging 2008;12 (1):22–2.
34. Kessler H, Bayer T, Bach D, Schneider-Axmann T, Supprian T, Herrmann W, Haber M, Multhaup G, Falkai P, Pajonk F-G. Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial. J Neural Transm 2008;115 (8):1181–1187. doi:10.1007/s00702-008-0080-1
35. Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redox-Active Metals, Oxidative Stress, and Alzheimer’s Disease Pathology. Annals of the New York Academy of Sciences 2004;1012 (1):153–163. doi:10.1196/annals.1306.012
36. Morris M, Evans DA, Bienias JL, et al. DIetary fats and the risk of incident alzheimer disease. Archives of Neurology 2003;60 (2):194–200. doi:10.1001/archneur.60.2.194
37. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 2004;62 (9):1573–157.
38. Sparks DL, Schreurs BG. Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer’s disease. Proceedings of the National Academy of Sciences 2003;100 (19):11065–11069. doi:10.1073/pnas.1832769100
39. Schwarzbach E, Bonislawski DP, Xiong G, Cohen AS. Mechanisms underlying the inability to induce area CA1 LTP in the mouse after traumatic brain injury. Hippocampus 16 2006;(6):541–550. doi:10.1002/hipo.20183
40. Tonkikh A, Janus C, El-Beheiry H, Pennefather PS, Samoilova M, McDonald P, Ouanounou A, Carlen PL. Calcium chelation improves spatial learning and synaptic plasticity in aged rats. Experimental Neurology 2006;197 (2):291–300.
41. Bernard S, Enayati A, Roger H, Binstock T, Redwood L. The role of mercury in the pathogenesis of autism. Molecular Psychiatry 2002;7 (2):s42–S43
42. Goulet S, Doré FY, Mirault ME. Neurobehavioral changes in mice chronically exposed to methylmercury during fetal and early postnatal development. Neurotoxicology and Teratology 2003;25 (3):335–347.
43. Eddins D, Petro A, Pollard N, Freedman JH, Levin ED. Mercury-induced cognitive impairment in metallothionein-1/2 null mice. Neurotoxicol Teratol 2008;30 (2):88–95. doi:10.1016/j.ntt.2007.12.005S0892-0362(07)00365-0 [pii]
44. Park JD, Liu Y, Klaassen CD. Protective effect of metallothionein against the toxicity of cadmium and other metals. Toxicology 2001;163 (2–3):93–100.
45. Tamm C, Duckworth J, Hermanson O, Ceccatelli S. High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. Journal of Neurochemistry 2006;97 (1):69–78. doi:10.1111/j.1471-4159.2006.03718.x
46. Ray AL, Semba RD, Walston J, Ferrucci L, Cappola AR, Ricks MO, Xue Q-L, Fried LP. Low Serum Selenium and Total Carotenoids Predict Mortality among Older Women Living in the Community: The Women’s Health and Aging Studies. The Journal of Nutrition 2006;136 (1):172–17.
47. Ducros V, Andriollo-Sanchez M, Arnaud J, Meunier N, Laporte F, Hininger-Favier I, Coudray C, Ferry M, Roussel A-M. Zinc supplementation does not alter plasma homocysteine, vitamin B12 and red blood cell folate concentrations in French elderly subjects. Journal of Trace Elements in Medicine and Biology 2009;23 (1):15–20.
48. Gao S, Jin Y, Unverzagt FW, Ma F, Hall KS, Murrell JR, Cheng Y, Shen J, Ying B, Ji R, Matesan J, Liang C, Hendrie HC. Trace element levels and cognitive function in rural elderly Chinese. Journals of Gerontology- Series A Biological Sciences and Medical Sciences 2008;63 (6):635–64.
49. Bomboi G, Marchione F, Sepe-Monti M, De Carolis A, Bianchi V, Medda E, Pino A, Bocca B, Forte G, D’Ippolito C, Giubilei F. Correlation between metal ions and clinical findings in subjects affected by Alzheimer’s disease. Ann Ist Super Sanita 2005;41 (2):205–21.
50. Dong J, Robertson JD, Markesbery WR, Lovell MA. Serum Zinc in the Progression of Alzheimer’s Disease. Journal of Alzheimer’s Disease 2008;15 (3):443–45.
51. Mocchegiani E, Giacconi R, Costarelli L, Muti E, Cipriano C, Tesei S, Pierpaoli S, Giuli C, Papa R, Marcellini F, Gasparini N, Pierandrei R, Piacenza F, Mariani E, Monti D, Dedoussis G, Kanoni S, Herbein G, Fulop T, Rink L, Jajte J, Malavolta M. Zinc deficiency and IL-6-174G/C polymorphism in old people from different European countries: Effect of zinc supplementation. ZINCAGE study. Experimental Gerontology 2008;43 (5):433–444.
52. Planas M, Conde M, Audivert S, Pérez-Portabella C, Burgos R, Chacón P, Rossello J, Boada M, Tàrraga LL. Micronutrient supplementation in mild Alzheimer disease patients. Clinical Nutrition 2004;23 (2):265–27.
53. Boveris A, Navarro A. Brain mitochondrial dysfunction in aging. IUBMB Life 2008;60 (5):308–314. doi:10.1002/iub.46
54. Roussel AM, Ferry M. Stress oxydant et vieillissement. Nutrition Clinique Et Metabolisme 2002;16:285–29.
55. Sánchez-Rodríguez MA, Santiago E, Arronte-Rosales A, Vargas-Guadarrama LA, Mendoza-Núñez VM. Relationship between oxidative stress and cognitive impairment in the elderly of rural vs. urban communities. Life Sciences 78 2006;(15):1682–1687.
56. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiology of aging 2003;24 (7):915–91.
57. Sánchez-Rodríguez MA, Retana-Ugalde R, Ruíz-Ramos M, Muñoz-Sánchez JL, Alberto Vargas-Guadarrama L, Mendoza-Núñez VM. Efficient antioxidant capacity against lipid peroxide levels in healthy elderly of Mexico City. Environmental Research 2005;97 (3):322–329.
58. Friedrich MJ. Scientists probe roles of mitochondria in neurological disease and injury. JAMA 2004;291 (6):679–681. doi:10.1001/jama.291.6.679291/6/679 [pii]
59. Schuessel K, Leutner S, Cairns NJ, Müller WE, Eckert A. Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer’s disease brain. J Neural Transm 2004;111 (9):1167–1182. doi:10.1007/s00702-004-0156-5
60. Sultana R, Reed T, Butterfield DA. Redox Proteomics and Metabolic Proteins in Brain of Subjects with Alzheimer’s Disease, Mild Cognitive Impairment, and Models Thereof. In: Neural Degeneration and Repair. Wiley-VCH Verlag GmbH & Co. KGaA/, 2008;pp 181–207. doi:10.1002/9783527622467.ch9
61. Baldeiras I, Santana I, Proenca MT, Garrucho MH, Pascoal R, Rodrigues A, Duro D, Oliveira CR. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer’s disease. J Alzheimers Dis 2008;15 (1):117–12.
62. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease. Neuroscience Letters 2010;469 (1):6–10.
63. López N, Tormo C, De Blas I, Llinares I, Alom J. Oxidative Stress in Alzheimer’s Disease and Mild Cognitive Impairment with High Sensitivity and Specificity. Journal of Alzheimer’s Disease 2013;33 (3):823–829. doi:10.3233/JAD-2012.2152.
64. Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LMM, Moreira WL, de Melo Loureiro AP, de souza-Talarico JN, Smid J, Porto CS, de Campos Bottino CM, Nitrini R, de Moraes Barros SB, Camarini R, Marcourakis T. Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer’s Disease. Journal of Alzheimer’s Disease 2011; 26 (1):59–68. doi:10.3233/JAD-2011.11028.
65. Mórocz M, Kálmán J, Juhász A, Sinkó I, McGlynn AP, Downes CS, Janka Z, Raskó I. Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer’s disease. Neurobiology of aging 2002;23 (1):47–53.
66. Migliore L, Fontana I, Trippi F, Colognato R, Coppedè F, Tognoni G, Nucciarone B, Siciliano G. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiology of aging 2005;26 (5):567–57.
67. Smith MA, Nunomura A, Zhu X, Takeda A, Perry G. Metabolic, Metallic, and Mitotic Sources of Oxidative Stress in Alzheimer Disease. Antioxidants & Redox Signaling 2 2000;(3):413–42.
68. Blair IA. Lipid hydroperoxide-mediated DNA damage. Experimental Gerontology 2001;36 (9):1473–1481.
69. von Zglinicki T, Bürkle A, Kirkwood TBL. Stress, DNA damage and ageing — an integrative approach. Experimental Gerontology 2001;36 (7):1049–1062.
70. Lee LK, Shahar S, Rajab N. Serum folate concentration, cognitive impairment, and DNA damage among elderly individuals in Malaysia. Nutrition Research 2009;29 (5):327–334.
71. Dorszewska J, Adamczewska-Goncerzewicz Z. Oxidative damage to DNA, p53 gene expression and p53 protein level in the process of aging in rat brain. Respiratory Physiology & Neurobiology 2004;139 (3):227–236.
72. Gedik CM, Grant G, Morrice PC, Wood SG, Collins AR. Effects of age and dietary restriction on oxidative DNA damage, antioxidant protection and DNA repair in rats. Eur J Nutr 2005;44 (5):263–272. doi:10.1007/s00394-004-0520-0
73. Borgesius NZ, de Waard MC, van der Pluijm I, Omrani A, Zondag GCM, van der Horst GTJ, Melton DW, Hoeijmakers JHJ, Jaarsma D, Elgersma Y. Accelerated Age-Related Cognitive Decline and Neurodegeneration, Caused by Deficient DNA Repair. The Journal of Neuroscience 2011;31 (35):12543–12553
74. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005;64:1152–115.
75. Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer’s disease. Nucleic Acids Research 2007;35 (22):7497–7504. doi:10.1093/nar/gkm821
76. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer’s disease. Journal of Neurochemistry 2005;93 (4):953–962. doi:10.1111/j.1471-4159.2005.03053.x
77. Martin LJ. Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases. Pharmaceuticals 2010;3 (4):839–91.
78. Reddy PH. Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med 2008;10 (4):291–315. doi:10.1007/s12017-008-8044-z
79. Reddy PH. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer’s disease. CNS Spectr 2009;14 (8 Suppl 7):8–13; discussion 16–18.
80. Schon Eric A, Przedborski S. Mitochondria: The Next (Neurode)Generation. Neuron 2011;70 (6):1033–105.
81. Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA. Role of mitochondrial dysfunction in Alzheimer’s disease. Journal of Neuroscience Research 2002;70 (3):357–360. doi:10.1002/jnr.10389
82. Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schüssel K, Müller WE. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer’s disease. Biochemical Pharmacology 2003;66 (8):1627–1634.
83. Bush AI. The metallobiology of Alzheimer’s disease. Trends in Neurosciences 2003;26 (4):207–214.
84. Perry G, Taddeo M, Petersen R, Castellani R, Harris PR, Siedlak S, Cash A, Liu Q, Nunomura A, Atwood C, Smith M. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals 2003;16 (1):77–81. doi:10.1023/a:1020731021276
85. Zhu X, Raina AK, Lee H-g, Casadesus G, Smith MA, Perry G. Oxidative stress signalling in Alzheimer’s disease. Brain Research 2004;1000 (1–2):32–39.
86. Coskun PE, Wyrembak J, Derbereva O, Melkonian G, Doran E, Lott IT, Head E, Cotman CW, Wallace DC. Systemic mitochondrial dysfunction and the etiology of Alzheimer’s disease and down syndrome dementia. J Alzheimers Dis 2010;20 Suppl 2:S293–310. doi:10.3233/JAD-2010-1003515041W7K40R382600 [pii]
87. Yu R-A, Chen H-J, He L-F, Chen B, Chen X-M. Telomerase Activity and Telomerase Reverse Transcriptase Expression Induced by Selenium in Rat Hepatocytes. Biomedical and Environmental Sciences 2009;22 (4):311–317.
88. Liu Y, Bohr VA, Lansdorp P. Telomere, telomerase and aging. Mechanisms of Ageing and Development 2008;129 (1–2):1–2.
89. O’sullivan J, Risques RA, Mandelson MT, Chen L, Brentnall TA, Bronner MP, MacMillan MP, Feng Z, Siebert JR, Potter JD, Rabinovitch PS. Telomere Length in the Colon Declines with Age: a Relation to Colorectal Cancer? Cancer Epidemiology Biomarkers & Prevention 2006;15 (3):573–577. doi:10.1158/1055-9965.epi-05.054.
90. von Zglinicki T, Martin-Ruiz CM, Saretzki G. Telomeres, cell senescence and human ageing. Signal Transduction 2005;5 (3):103–114. doi:10.1002/sita.200400049
91. Kawanishi S, Oikawa S. Mechanism of Telomere Shortening by Oxidative Stress. Annals of the New York Academy of Sciences 2004;1019 (1):278–284. doi:10.1196/annals.1297.047
92. Thomas P, O’Callaghan NJ, Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer’s disease. Mechanisms of Ageing and Development 2008;129 (4):183–190.
93. Jenkins EC, Velinov MT, Ye L, Gu H, Li S, Brooks SS, Pang D, Devenny DA, Zigman WB, Schupf N, Silverman WP. Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiology of aging 2006;27 (7):941–94.
94. O’Callaghan N, Bull C, Fenech M. Elevated plasma magnesium and calcium may be associated with shorter telomeres in older South Australian women. The Journal Of Nutrition, Health & Aging 2014;18 (2):131–136. doi:10.1007/s12603-013-0401-4
95. Liu Q, Wang H, Hu D, Ding C, Xu H, Tao D. Effects of trace elements on the telomere lengths of hepatocytes L-02 and hepatoma cells SMMC-7721. Biol Trace Elem Res 2004;100 (3):215–227. doi:10.1385/bter:100:3:215
96. Houben JMJ, Moonen HJJ, van Schooten FJ, Hageman GJ. Telomere length assessment: Biomarker of chronic oxidative stress? Free Radical Biology and Medicine 2008;44 (3):235–246.
97. Liu Q, Wang H, Hu DC, Ding CJ, Xiao H, Xu HB, Shu BH, Xu SQ. Effects of sodium selenite on telomerase activity and telomere length. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2003;35 (12):1117–112.
98. Cui QH, Tang CC, Huang YG. Effects of lead and selenium on telomere binding protein Rap1p, telomerase and telomeric DNA in Saccharomyces cerevisiae. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2002;34 (2):240–24.
99. Ferry M, Roussel AM. Micronutrient status and cognitive decline in ageing. European Geriatric Medicine 2011;2 (1):15–21.
100. Meydani M. Antioxidants and Cognitive Function. Nutrition Reviews 2001;59 (8):s75–S82. doi:10.1111/j.1753-4887.2001.tb05505.x
101. Mocchegiani E, Malavolta M, Marcellini F, Pawelec G. Zinc, oxidative stress, genetic background and immunosenescence: implications for healthy ageing. Immun Ageing 2006;3:6
102. Sharif R, Thomas P, Zalewski P, Fenech M. The role of zinc in genomic stability. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2012;733 (1–2):111–121.